ANAB (STOCKS)
AnaptysBio, Inc. Common Stock
$53.020000
+2.780000 (+5.53%)
Prev close: $50.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Daniel R. Faga
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,483.10M
- Employees
- 136
- P/E (TTM)
- -17.82
- P/B (TTM)
- -47.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
10
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.52 | $-1.47 | +1.9881 | +135.42% |
|
Jun 2025 (Q2)
|
$-1.34 | $-1.57 | +0.2325 | +14.79% |
|
Mar 2025 (Q1)
|
$-1.28 | $-1.28 | -0.0015 | -0.12% |
|
Dec 2024 (Q4)
|
$-0.72 | $-1.65 | +0.9315 | +56.40% |
Financial Statements
| Assets | $353.10M |
| Current Assets | $330.65M |
| Accounts Receivable | $75.69M |
| Other Current Assets | $254.97M |
| Noncurrent Assets | $22.45M |
| Fixed Assets | $1.50M |
| Other Non-current Assets | $20.95M |
| Liabilities | $382.51M |
| Current Liabilities | $38.10M |
| Accounts Payable | $2.89M |
| Wages | $9.01M |
| Other Current Liabilities | $26.20M |
| Noncurrent Liabilities | $344.41M |
| Equity | -$29.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$29.42M |
| Liabilities And Equity | $353.10M |